|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
|
GB9910807D0
(en)
|
1999-05-10 |
1999-07-07 |
Prometic Biosciences Limited |
Novel detoxification agents and their use
|
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
|
EP1282606B1
(en)
|
2000-05-08 |
2015-04-22 |
Janssen Pharmaceutica NV |
Hiv replication inhibiting pyrimidines and triazines
|
|
JP2005500294A
(ja)
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ７に対するピリミジン阻害剤
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
AU2002316421B2
(en)
|
2001-06-26 |
2008-05-15 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-ALPHA expression
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
EP1438053B1
(de)
|
2001-10-17 |
2008-09-10 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
|
|
JP4072615B2
(ja)
|
2002-03-05 |
2008-04-09 |
独立行政法人産業技術総合研究所 |
配位子を有する複素環化合物及びその製造方法、及びこの複素環化合物を用いる金属元素の固定化膜
|
|
CN1717396A
(zh)
*
|
2002-11-28 |
2006-01-04 |
舍林股份公司 |
Chk－、Pdk－和Akt－抑制嘧啶,其制备及作为药物的用途
|
|
US7279576B2
(en)
|
2002-12-31 |
2007-10-09 |
Deciphera Pharmaceuticals, Llc |
Anti-cancer medicaments
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
CL2004000306A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
|
|
CN100549014C
(zh)
|
2003-07-16 |
2009-10-14 |
詹森药业有限公司 |
作为糖原合酶激酶3抑制剂的三唑并嘧啶衍生物
|
|
US8178671B2
(en)
|
2003-07-30 |
2012-05-15 |
Rigel Pharmaceuticals, Inc. |
Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
|
|
JP4741491B2
(ja)
|
2003-08-07 |
2011-08-03 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
抗増殖剤としての２，４−ピリミジンジアミン化合物および使用
|
|
WO2005118544A2
(en)
|
2004-05-18 |
2005-12-15 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
|
UA92150C2
(ru)
|
2004-06-04 |
2010-10-11 |
Арена Фармасьютикалз, Инк. |
Замещенные производные арила и гетероарила как модуляторы метаболизма и для профилактики и лечения связанных с ним расстройств
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
CA2592118C
(en)
|
2004-12-23 |
2015-11-17 |
Deciphera Pharmaceuticals, Llc |
Urea derivatives as enzyme modulators
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
JP5369257B2
(ja)
|
2006-02-15 |
2013-12-18 |
アッヴィ・インコーポレイテッド |
新規なアセチル−ＣｏＡカルボキシラーゼ（ＡＣＣ）阻害薬およびそれらの糖尿病、肥満および代謝症候群での使用
|
|
BRPI0711628A2
(pt)
|
2006-05-15 |
2011-12-06 |
Irm Llc |
composto, composição farmacêutica, uso e processo para preparação do composto
|
|
US20070293494A1
(en)
|
2006-06-15 |
2007-12-20 |
Djung Jane F |
2-Anilino-4-(Heterocyclic) Amino-Pyrimidines
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
CN101611035A
(zh)
|
2006-12-28 |
2009-12-23 |
大正制药株式会社 |
吡唑并嘧啶化合物
|
|
US8143293B2
(en)
|
2007-04-20 |
2012-03-27 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
|
|
JP2011500727A
(ja)
|
2007-10-22 |
2011-01-06 |
シェーリング コーポレイション |
Ｇｐｒ１１９の活性のモジュレーターとしての二環式ヘテロ環誘導体およびその使用
|
|
US20100056524A1
(en)
*
|
2008-04-02 |
2010-03-04 |
Mciver Edward Giles |
Compound
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
ES2711249T3
(es)
|
2008-06-27 |
2019-04-30 |
Celgene Car Llc |
Compuestos de heteroarilo y usos de los mismos
|
|
AU2009308853A1
(en)
|
2008-10-29 |
2010-05-06 |
Deciphera Pharmaceuticals, Llc |
Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2010111406A2
(en)
|
2009-03-24 |
2010-09-30 |
Myriad Pharmaceuticals, Inc. |
Compounds and therapeutic uses thereof
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
SG181965A1
(en)
|
2009-12-30 |
2012-08-30 |
Avila Therapeutics Inc |
Ligand-directed covalent modification of protein
|
|
AU2011248441A1
(en)
|
2010-04-29 |
2012-12-20 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites
|
|
AU2011245248B2
(en)
|
2010-04-29 |
2016-01-07 |
Deciphera Pharmaceuticals, Llc |
Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites
|
|
WO2012110773A1
(en)
|
2011-02-17 |
2012-08-23 |
Cancer Therapeutics Crc Pty Limited |
Fak inhibitors
|
|
MX2014006126A
(es)
|
2011-11-22 |
2015-03-19 |
Deciphera Pharmaceuticals Llc |
Amidas de piridona y analogos que exhiben actividades anticancerigenas y antiproliferativas.
|
|
JP6117816B2
(ja)
|
2011-11-29 |
2017-04-19 |
ジェネンテック， インコーポレイテッド |
Ｌｒｒｋ２モジュレーターとしてのアミノピリミジン誘導体
|
|
CA2850705C
(en)
|
2011-11-29 |
2020-03-10 |
F. Hoffmann-La Roche Ag |
2-(phenyl or pyrid-3-yl)aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
|
|
CN104093426B
(zh)
|
2011-11-30 |
2019-06-28 |
健泰科生物技术公司 |
用于lrrk2的正电子发射体层摄影(pet)成像的氟-18和碳-11标记的放射性配体
|
|
WO2013134298A1
(en)
|
2012-03-07 |
2013-09-12 |
Deciphera Pharmaceuticals, Llc |
Raf inhibitor compounds
|
|
AR090151A1
(es)
|
2012-03-07 |
2014-10-22 |
Lilly Co Eli |
Compuestos inhibidores de raf
|
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
WO2014145015A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145029A2
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145023A1
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
SG11201507660TA
(en)
|
2013-03-15 |
2015-10-29 |
Deciphera Pharmaceuticals Llc |
2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
US9382228B2
(en)
|
2013-03-15 |
2016-07-05 |
Deciphera Pharmaceuticals, Llc |
N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2014145004A1
(en)
|
2013-03-15 |
2014-09-18 |
Deciphera Pharmaceuticals, Llc |
Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
CA2917667A1
(en)
|
2013-07-09 |
2015-01-15 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
|
BR112016005881A2
(pt)
|
2013-09-18 |
2017-09-12 |
Beijing Hanmi Pharmaceutical Co Ltd |
composto, composição farmacêutica e uso do composto
|
|
CN104262328B
(zh)
|
2013-09-18 |
2016-09-07 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
|
MY184733A
(en)
|
2013-10-18 |
2021-04-20 |
Eisai R&D Man Co Ltd |
Pyrimidine fgfr4 inhibitors
|
|
SG11201602387RA
(en)
|
2013-10-21 |
2016-05-30 |
Merck Patent Gmbh |
Heteroaryl compounds as btk inhibitors and uses thereof
|
|
US9457019B2
(en)
|
2013-11-07 |
2016-10-04 |
Deciphera Pharmaceuticals, Llc |
Methods for inhibiting tie-2 kinase useful in the treatment of cancer
|
|
US20150284341A1
(en)
|
2014-04-07 |
2015-10-08 |
Catylix, Inc. |
Fluoroalkyl-substituted derivatives of pyridine, pyrimidine, and pyrazine
|
|
US10266549B2
(en)
|
2014-08-25 |
2019-04-23 |
Salk Institute For Biological Studies |
ULK1 inhibitors and methods using same
|
|
US10336734B2
(en)
|
2015-08-02 |
2019-07-02 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
|
US11028080B2
(en)
|
2016-03-11 |
2021-06-08 |
Denali Therapeutics Inc. |
Substituted pyrimidines as LRKK2 inhibitors
|
|
CA3054809A1
(en)
|
2017-02-28 |
2018-09-07 |
The General Hospital Corporation |
Uses of pyrimidopyrimidinones as sik inhibitors
|
|
US20200129489A1
(en)
|
2017-05-30 |
2020-04-30 |
Deciphera Pharmaceuticals, Llc |
Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha
|
|
KR20200115606A
(ko)
|
2018-01-31 |
2020-10-07 |
데시페라 파마슈티칼스, 엘엘씨. |
비만 세포증의 치료를 위한 병용 요법
|
|
KR20200143709A
(ko)
|
2018-04-10 |
2020-12-24 |
뉴로포레 테라피스, 인코포레이티드 |
Pi3-키나제 및 오토파지 경로의 조절인자로서의 트리-치환된 아릴 및 헤테로아릴 유도체
|
|
HRP20231478T1
(hr)
|
2018-12-28 |
2024-04-26 |
Deciphera Pharmaceuticals, Llc |
Csf1r inhibitori za primjenu u liječenju raka
|
|
US11530206B2
(en)
|
2019-05-10 |
2022-12-20 |
Deciphera Pharmaceuticals, Llc |
Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
RS64755B1
(sr)
|
2019-05-10 |
2023-11-30 |
Deciphera Pharmaceuticals Llc |
Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primene
|
|
KR20220024605A
(ko)
|
2019-06-17 |
2022-03-03 |
데시페라 파마슈티칼스, 엘엘씨. |
아미노피리미딘 아미드 자가포식 억제제 및 이의 사용 방법
|